An offer might set you back approximately USD 15bn in the long-term, according to Bloomberg.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/astrazeneca-has-eyes-on-summits-billion-dollar-cancer-drug/
AstraZeneca has eyes on Summit’s billion-dollar cancer drug
赞 (0)
关于作者
Media: AstraZeneca CEO wants to move listing to US
上一篇
5 7 月, 2025 4:18 上午
EU hopes for tariff agreement with US – but prepares for collapse
下一篇
5 7 月, 2025 4:18 上午
相关推荐
-
Upcoming steer-by-wire SUV will remind you of the Range Rover
That’s not an Array Vagabond you’re considering, that’s the Xpeng GX. It’s the Chinese carmaker’s initial full-size crossover, loading some major tech…
-
India’s Sarla Aviation raises USD10 million in funding – to unveil prototype eVTOL on January 17
Indian eVTOL designer Sarla Air travel has actually increased USD 10 million in Collection A1 financing. The round was led by Accel and Nikhil Kamath, with engagement from angel ca…
-
Saudi Arabia Perfume Market Report 2025-2033: Rise in Intense Competition and High Import Costs Could Hamper the $3.5+ Billion Industry – ResearchAndMarkets.com
DUBLIN–( COMPANY CORD)– The “Saudi Arabia Fragrance Market by Kind, Worth, Sex, and Firm Evaluation 2025-2033” record has actually been contributed to Resea…
-
Resumen: STMicroelectronics se une a Quintauris como sexto accionista
MÚNICH–( ORGANIZATION CORD)– STMicroelectronics (NYSE: STM), líder internacional en semiconductores que presta servicio a clientes de todo el espectro de aplicaciones e…
-
IBM: Data silos are holding back enterprise AI
According to IBM, the key obstacle keeping back business AI isn’t the innovation itself however the consistent concern of information silos. Ed Lovely, VP and Principal Infor…
